ArtScience is a privately held company founded in 2012. The company is built on a highly skilled team with exceptional experiences in research and development and project management in big pharma research. The staff encompasses many years of experience covering everything from running drug hunting projects to delivering them to the clinic.

ArtScience is dedicated to drug development support for smaller biotech companies and other life science based companies with need for drug research and development support.

Henrik Vissing , Director

Twenty years of international experience within pharmaceutical research and development as line manager and project leader.

Lines roles as Associated Director, Translational Sciences at AstraZaneca and Team Leader at Novo Nordisk.

Project management of translational medicine drug projects in clinical development up to Phase lla.

Scientific knowledge and business experience in different disease areas, including inflamation, respiratory. diabetes and metabolism.

Expertise in Bioinformatics /Medical Informatics strategies, development and project management. Chairman of the Board of the Danish Center for Scienctific Computing (DCSC) at the Danish Ministry of Science, Technology and Innovation.

Assistant Professor in Molecular Genetics at the Mt Sinai Medical Center, New York.

Tomas Eriksson PhD, Senior partner

More than 25 years in big pharma and research. Experienced Project Leader/ Manager Preclinical Research and Early Development at AstraZeneca

Line roles as Associate Director, Team Leader and Chemist in Medicinal Chemistry

Expertise areas: Medicinal Chemistry, Patents, Preclinical research, process and project management, Candidate drug properties, Early development up through phase IIa.